Search Results for: IPS cell

Stem cell & regenerative medicine good news & pubs

Rosie-Barrero-CIRM-stem-cell-good-news

There is always plenty of complicated, mixed-bag news on the stem cell and regenerative medicine front so it’s great to highlight when there’s some good news out there. Today’s post includes several such upbeat items. At the bottom I’ve included a list of some recent interesting publications as well. Good news on vision front: jCyte

Stem cell & regenerative medicine good news & pubs Read More »

What are stem cells in Arabic: ماهي الخلايا الجذعية؟

-الخلايا-الجذعية؟

This post in Arabic on “خلايا جذعية”  entitled”ماهي الخلايا الجذعية؟” has been updated in 2020, and is part of our SCOPE stem cells not lost in translation project. You can learn more about the educational outreach project and read the other 33 languages there at that link. ماهي الخلايا الجذعية؟ يتكون جسم الإنسان من العديد

What are stem cells in Arabic: ماهي الخلايا الجذعية؟ Read More »

Lessons from when embryonic stem cell research was illegal

James-Sherley

We kind of take for granted these days that embryonic stem cell research can proceed without any restrictions, at least at the federal level. However, in the early days of blogging here on The Niche the big debate and battle were over federal funding of embryonic stem cell research. Things got very complicated and for

Lessons from when embryonic stem cell research was illegal Read More »

“Not lost in translation” stem cell outreach project caps 2 million reads

languages

Many years ago I started a “not lost in translation” outreach project here on The Niche called SCOPE, meaning Stem Cell Outreach Program for Education. I thought it’d be useful for people all around the world who didn’t necessarily speak English to be able to get authoritative, factual data on stem cells. That was about

“Not lost in translation” stem cell outreach project caps 2 million reads Read More »

COVID-19 cellular medicine buzz: Mesoblast, FTC hammer, more

cell therapy for COVID

  It’s been a busy week for the cellular and regenerative medicine space for COVID-19 news with some possible ups including for Mesoblast and some definite downs. Starting with the more positive media buzz with have Mesoblast. Mesoblast made COVID19 news “Thinly traded Mesoblast Limited (NASDAQ:MESO) rockets 51% premarket on average volume in reaction to its announcement of an

COVID-19 cellular medicine buzz: Mesoblast, FTC hammer, more Read More »

Texas Gov Abbott pandemic hypocrisy on abortion vs. stem cell clinics

Greg-Abbott-Texas-stem-cells-COVID-abortion

Texas Governor Greg Abbott has effectively banned abortions in his state during the COVID-19 pandemic, but his reasoning makes no sense and is inconsistent with his policies more generally on health-care clinics. The Tribune notes that while “Abbott’s original ban was intended to preserve medical resources”, his own statements contradict that, including “On Friday, he

Texas Gov Abbott pandemic hypocrisy on abortion vs. stem cell clinics Read More »

Cell therapy trials for COVID-19 accelerate & some early reports

MultiStem-Athersys-cell-therapy-COVID-19

Could various kinds of cell therapy help patients with COVID-19? A variety of cell therapies, mostly focused on mesenchymal stromal/stem cells (MSCs), have gotten cleared quickly in the U.S., China, and Israel and possibly other countries to be tested in patients with the novel coronavirus. I hope at least one proves helpful. It’s mostly a

Cell therapy trials for COVID-19 accelerate & some early reports Read More »

Who IS this!? Surprising phone survey of stem cell clinics on their COVID-19 pandemic status

iPhone-stem-cell-clinics-pandemic

It’s not every day that I call a bunch of stem cell clinics to say “hi”, but yesterday I called some of them during a needed lunch break from grant writing to see what they were doing about their operations during the COVID-19 pandemic. The impetus for this survey of a sort was a question

Who IS this!? Surprising phone survey of stem cell clinics on their COVID-19 pandemic status Read More »